( en | de | ru )

 

Disambiguation

From post

копироватьудалитьдобавить публикацию в буфер
Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era

, , , , , , и . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 (14): 2373–2380 (2010)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed.

Jan Kuhnt

Endovaskuläre Stentgrafttherapie der Typ B Aortendissektion: Determinanten des postinterventionellen Überlebens. Uni Duisburg-Essen, (2009)

Irmhild Kuhnt

Sigrid Kuhnt

Dietmar Kuhnt

Gerald Kuhnt

 

Другие публикации лиц с тем же именем

Are renal adverse effects of hydroxyethyl starches merely a consequence of their incorrect use?, , , , , , , и . Wiener klinische Wochenschrift, 123 (5-6): 145–155 (2011)Intensive insulin therapy and pentastarch resuscitation in severe sepsis, , , , , , , , , и 13 other автор(ы). The New England journal of medicine, 358 (2): 125–139 (2008)Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study, , , , , , , , , и 8 other автор(ы). The Lancet Oncology, 9 (5): 435–444 (2008)CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group, , , , , , , , , и 14 other автор(ы). The Lancet. Oncology, 7 (5): 379–391 (2006)Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial, , , , , , , , , и 19 other автор(ы). JAMA, 307 (22): 2390–2399 (2012)Standard International prognostic index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era, , , , , , и . Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 (14): 2373–2380 (2010)Gene polymorphisms in the heme degradation pathway and outcome of severe human sepsis, , , , , , , , , и 6 other автор(ы). Shock (Augusta, Ga.), 38 (5): 459–465 (2012)CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group, , , , , , , , , и 11 other автор(ы). The Lancet Oncology, 12 (11): 1013–1022 (2011)